CROI 2015 Program and Abstracts

Poster Listings

1002 Return to HIV-Related Medical Care After a Hiatus of ≥ 1 Year, New York State, 2013 Carol-Ann Swain 4 ; Daniel Gordon 4 ; Jessica L. Simpson 3 ; Bridget J. Anderson 4 ; Bruce D. Agins 1 ; Lou C. Smith 2 1 Office of the Medical Director, New York State Department of Health, New York, NY, US; 2 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US; 3 Division of Epidemiology, Evaluation and Research, New York State Department of Health, Albany, NY, US; 4 New York State Department of Health, Albany, NY, US 1003 Care-Cascade Status of Partners of Persons With New HIV Infections in North Carolina Anna B. Cope 1 ; Lisa Hightow-Weidman 1 ; JoAnn D. Kuruc 1 ; Jenni Marmorino 1 ; Steve Beagle 1 ; Philip J. Peters 2 ; Cynthia L. Gay 1 1 University of North Carolina, Chapel Hill, NC, US; 2 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US 1004 The Role of HIV Status Disclosure in Retention in Care and Viral-Load Suppression Latesha E. Elopre ; AndrewWestfall; Michael J. Mugavero; Anne Zinski; Greer Burkholder; Edward Hook; NicholasVanWagoner University of Alabama at Birmingham, Birmingham, AL, US 1005 Alcohol and Substance Use and Timing of Presentation to HIV Care Across the United States Jesse Abbott Klafter 1 ; Daniel R. Drozd 3 ; Michael J. Mugavero 2 ; Katerina Christopoulos 4 ; ChristopherW. Mathews 7 ; Joseph J. Eron 8 ; Kenneth H. Mayer 6 ; Matthew Mimiaga 5 ; Mari Kitahata 3 ; Heidi M. Crane 3 Center for AIDS Research Network of Integrated Clinical Systems (CNICS) 1 University of Washington, Seattle, WA, US; 2 University of Alabama at Birmingham, Birmingham, AL, US; 3 University of Washington, Seattle, WA, US; 4 University of California San Francisco, San Francisco, CA, US; 5 Harvard Medical School, Boston, MA, US; 6 Fenway Health, Boston, MA, US; 7 University of California San Diego (UCSD), San Diego, CA, US; 8 University of North Carolina, Chapel Hill, NC, US 1006 Marijuana Use and Its Nuanced RelationshipWith HIV Treatment ContinuumMetrics John A. Schneider 1 ; Ethan Morgan 1 ; Stuart Michaels 2 ; Britt Skaathun 1 ; LindsayYoung 1 ; RobertW. Coombs 3 ; Phil Schumm 1 ; DexterVoisin 1 ; Sam Friedman 4 UConnect StudyTeam 1 University of Chicago, Chicago, IL, US; 2 NORC, Chicago, IL, US; 3 University of Washington, Seattle, WA, US; 4 National Development Research Institute, New York, NY, US 1007 “Test-and-Treat”in the Netherlands Ard van Sighem 1 ; Luuk Gras 1 ; Eline Op de Coul 2 ; Daniela Bezemer 1 ; Michiel van Agtmael 3 ; Godelieve de Bree 4 ; Peter Reiss 1 On behalf of the ATHENA National Observational HIV Cohort 1 Stichting HIV Monitoring, Amsterdam, Netherlands; 2 National Institute for Public Health and the Environment, Bilthoven, Netherlands; 3 VU University Medical Centre, Amsterdam, Netherlands; 4 Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands 1008 Estimates of HIV Prevalence, Proportion of Diagnosed Patients and Quality of Treatment in Switzerland Philipp Kohler 2 ; Axel J. Schmidt 3 ; Bruno Ledergerber 2 ; Pietro L. Vernazza 1 1 Cantonal Hospital St. Gallen, St. Gallen, Switzerland; 2 Universitätsspital Zürich, Zurich, Switzerland; 3 Federal Office of Public Health, Bern, Switzerland 1009 Medical Care Interruptions in HIV-infected Patients: Characteristics and Consequences Lise Cuzin 1 ; Pierre Dellamonica 2 ;YazdanYazdanpanah 7 ; Sabelline Bouchez 3 ; David Rey 6 ; Bruno Hoen 5 ; André Cabié 4 1 Toulouse University Hospital, Toulouse, France; 2 University Hospital, Nice, Nice, France; 3 University Hospital, Nantes, France; 4 University Hospital, Fort de France, France; 5 University Hospital, Pointe à Pitre, France; 6 University Hospital, Strasbourg, France; 7 Hôpital Bichat-Claude Bernard, APHM, Paris, France

994 CHARM-01, a Phase 1 Rectal Safety, Acceptability, PK/PD Study of 3 Tenofovir Gels Ian McGowan 1 ; Kathy Duffill 2 ; Charlene Dezzutti 1 ; Nicola Richardson-Harman 3 ; Mark A. Marzinke 4 ; Ross D. Cranston 1 ; Lisa Rohan 1 ; CraigW. Hendrix 4 ; Julie Elliott 5 ; Peter Anton 5 1 University of Pittsburgh, Pittsburgh, PA, US; 2 Magee-Womens Research Institute, Pittsburgh, PA, US; 3 Alpha StatConsult LLC, Damascus, MD, US; 4 Johns Hopkins University School of Medicine, Baltimore, MD, US; 5 David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, US

995 Female Condom Functionality in the Presence of a Vaginal Ring

Annalene M. Nel 1 ; Mildie Leuvennink 1 ; NelietteVan Niekerk 1 ;TerriWalsh 2 ; Ron Frezieres 2 1 International Partnership for Microbicides, Paarl, South Africa; 2 California Family Health Council Inc, Los Angeles, CA, US

TUESDAY, FEBRUARY 24, 2015 Session P-W1 Poster Session

Poster Hall

2:30 pm– 4:00 pm HIV Testing and the Continuum of Care in the IndustrializedWorld 996 Continuous Retention Predicts Viral Suppression Across the US and Canada Peter F. Rebeiro 1 ; Baligh R.Yehia 2 ; Kelly Gebo 3 ; Bryan Lau 3 ; Kenneth H. Mayer 4 ; Michael A. Horberg 5 ; Mari Kitahata 6 ; John Gill 7 ;Timothy Sterling 1 ; Stephen J. Gange 3 North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) 1 Vanderbilt University, Nashville, TN, US; 2 University of Pennsylvania, Philadelphia, PA, US; 3 Johns Hopkins University, Baltimore, MD, US; 4 Harvard University, Boston, MA, US; 5 Mid- Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, MD, US; 6 University of Washington, Seattle, WA, US; 7 University of Calgary, Alberta Health Services, Calgary, Canada 997 Disparities in HIV Viral-Load Suppression Among MSM, the HIV Outpatient Study, 2013 Kate Buchacz 1 ; Carl Armon 2 ; EllenTedaldi 3 ; Frank J. Palella 4 ; Richard Novak 5 ; DougWard 6 ; BenjaminYoung 7 ; Rachel Debes 2 ; Marcus Durham 1 ; JohnT. Brooks 1 1 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US; 2 Cerner Corporation, Vienna, VA, US; 3 Temple University School of Medicine, Philadelphia, PA, US; 4 Northwestern University, Chicago, IL, US; 5 University of Illinois at Chicago, Chicago, IL, US; 6 Dupont Circle Physicians Group, Washington, DC, US; 7 International Association of Providers in AIDS Care, Washington, DC, US 998 Early Linkage to HIV Care and Antiretroviral Therapy Use Among People Who Inject Drugs: 20 US Cities, 2009 and 2012 Brooke Hoots ;Teresa Finlayson; Dita Broz; Gabriela Paz-Bailey US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US 999 Late HIV Diagnosis in Metropolitan Areas of the United States and Puerto Rico H. Irene Hall 1 ;TianTang 2 ; Lorena Espinoza 1 1 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US; 2 ICF International, Atlanta, GA, US 1000 HIV Care During the Last Year of Life H. Irene Hall 1 ; Lorena Espinoza 1 ; Shericka Harris 2 ; Jing Shi 2 1 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US; 2 ICF International, Atlanta, GA, US 1001 Reductions in the Time FromHIV Infection to ART Initiation in New York City Sarah L. Braunstein 1 ; McKaylee Robertson 2 ; Julie Myers 1 ; Bisrat Abraham 3 ; Denis Nash 4 1 New York City Department of Health and Mental Hygiene, Queens, NY, US; 2 City University of New York, New York, NY, US; 3 Weill Cornell Medical College, New York, NY, US; 4 City University of New York School of Public Health, New York, NY, US

Poster Listings

76

CROI 2015